Valbiotis SA

ALVAL

Company Profile

  • Business description

    Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.

  • Contact

    12F rue Paul VATINE
    Perigny
    La Rochelle17180
    FRA

    T: +33 546286258

    http://www.valbiotis.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    55

Stocks News & Analysis

stocks

2 picks in an undervalued ASX sector

Investors may be too pessimistic about this industry.
stocks

AMD and OpenAI partnership

What does another huge AI deal mean for investors?
stocks

Undervalued ASX founder-led companies

Can this strategy pick the winners?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,244.8011.80-0.13%
CAC 408,060.1385.281.07%
DAX 4024,597.13211.350.87%
Dow JONES (US)46,796.36193.380.41%
FTSE 1009,548.8765.290.69%
HKSE26,829.46128.31-0.48%
NASDAQ22,978.77190.400.84%
Nikkei 22547,734.99215.89-0.45%
NZX 50 Index13,568.4837.190.27%
S&P 5006,752.0937.500.56%
S&P/ASX 2008,947.6010.80-0.12%
SSE Composite Index3,882.7820.250.52%

Market Movers